How many PhDs were kept in D&R?

[Anonymous]

All of this talk about B+L not doing research anymore is bunk. How many PhDs were laid off in D&R. Very few. PhDs are hired to do research. Research is alive and well at Bausch.

 

[Anonymous]

Development at B+L is finished. Of those who were not synergized in D&R there are two types left:

1. Worthless executives with guaranteed packages trying desperately to keep things going
2. Everyone else, who now knows they have to use every minute of the day working to find their next position. If they don't they all know they will be let go soon enough anyway, and they'll be in much worse shape than the initial round who at least got the B+L package.

 

[Anonymous]

It's just going to have a s l o w, s l o w death. But it will all be gone. That is MP's MO.

 

[Anonymous]

You are all wrong. After a slow rebuilding stage Valeant will expand R&D. That is why so few people in D&R in Rochester were let go.

 

[Anonymous]

You are all wrong. After a slow rebuilding stage Valeant will expand R&D. That is why so few people in D&R in Rochester were let go.

I find your ill conceived notions of the value of Rochester D&R most laughable. The only D&R that has any value at all are at the non-Rochester sites around the world - they're the only ones to produce anything tangible in line with the manufacturing facilities. Rochester should've been a ghost town years ago. This massive, bloated, top heavy organization was sucking too much off the top for way too long. Whether by the hand of Valeant or market forces, the day of reckoning has finally arrived.

 

[Anonymous]

You are all wrong. After a slow rebuilding stage Valeant will expand R&D. That is why so few people in D&R in Rochester were let go.

Exactly so. Right after the aliens land and MP can leverage their galactic eyewear technology.

 

[Anonymous]

If the people that typically perform research survive in an organization and the people that are responsible for Development and Quality are laid off guess what the emphasis of the organization will be in the future. The research people that survived will focus all of their attention on research regardless of the CEO emphasis on Development.

 

[Anonymous]

You are all wrong. After a slow rebuilding stage Valeant will expand R&D. That is why so few people in D&R in Rochester were let go.

Who in their right mind would come into the environment that now exists at the optics center (or any other R&D location for that matter) for an interview and take a position there? Nobody would. Not to mention, there is no infrastructure left to even arrange interviews or bring people in if you did want to hire them. The company is in a death spiral, everyone knows it and no one will be replaced when they leave. Why valeant bought the company to do this to it is beyond me, if all they wanted was the name and the pharma business they could have at least sold off lenses and surgical instead of just outright killing them.

 

[Anonymous]

Who in their right mind would come into the environment that now exists at the optics center (or any other R&D location for that matter) for an interview and take a position there? Nobody would. Not to mention, there is no infrastructure left to even arrange interviews or bring people in if you did want to hire them. The company is in a death spiral, everyone knows it and no one will be replaced when they leave. Why valeant bought the company to do this to it is beyond me, if all they wanted was the name and the pharma business they could have at least sold off lenses and surgical instead of just outright killing them.

The managers in charge after cutbacks are going to follow this philosophy. The managers have control over surgical, vision care and pharma. Their impression is that their job is to "wind down" B+L in surgical and vision care and build up pharma.

If surgical and Vision Care have any chance in the future at all they have to separate completely from these "Pharma" managers that feel that killing these two businesses or at least underfunding them is their mandate.

 

[Anonymous]

The managers in charge after cutbacks are going to follow this philosophy. The managers have control over surgical, vision care and pharma. Their impression is that their job is to "wind down" B+L in surgical and vision care and build up pharma.

If surgical and Vision Care have any chance in the future at all they have to separate completely from these "Pharma" managers that feel that killing these two businesses or at least underfunding them is their mandate.

Since both Valeant and the "Pharma" management now in control both have the opinion to "wind down" Vision Care and Surgical hopefully Valeant tries to sell Vision Care and maybe Surgical too. Why keep a business that you do not like. It is not in your core business and there are little synergies. There are synergies in Pharma. None in the other two businesses.

Valeant Please sell the Vision Care business since you are going to bleed and torture it if you keep it. Pharma is your favorite son. Give it and the people in it your support and let your Vision Care people go.